Effect of sodium-glucose cotransporter-2 inhibitor (SGLT2-i) in patients with LVAD: a systematic review and meta-analysis

被引:0
|
作者
Hasabo, E. A. [1 ,2 ]
Isik, B. [3 ]
Elgadi, A. [4 ]
Eljack, M. M. F. [5 ]
Yacuob, M. S. [1 ,2 ]
Alzomor, H. [1 ,2 ]
Sawabi, R. [1 ,2 ]
Sultan, S. [6 ]
Caliskan, K. [7 ]
Soliman, O. [1 ,2 ]
机构
[1] Univ Galway, CORRIB Core Lab, Galway, Ireland
[2] Galway Univ Hosp, Galway, Ireland
[3] Univ Limerick, Limerick, Ireland
[4] Univ Khartoum, Fac Med, Khartoum, Sudan
[5] Univ Bakht Alruda, Fac Med, Ad Duwaym, Sudan
[6] Univ Coll Hosp, Western Vasc Inst, Galway, Ireland
[7] Erasmus MC, Rotterdam, Netherlands
关键词
D O I
10.1093/eurheartj/ehae666.3355
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Sodium-glucose cotransporter-2 inhibitors (SGLT2) in frail or older people with type 2 diabetes and heart failure: a systematic review and meta-analysis
    Aldafas, Rami
    Crabtree, Tomas
    Alkharaiji, Mohammed
    Vinogradova, Yana
    Idris, Iskandar
    AGE AND AGEING, 2024, 53 (01)
  • [32] Disparities in Access to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i)
    Zhang, Donglan S.
    Rajan, Anand
    Islam, Shahidul
    Charytan, David M.
    Jacobson, Alan M.
    Divers, Jasmin
    DIABETES, 2023, 72
  • [33] Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Acute Coronary Syndrome
    Singh, Sahib
    Bliden, Kevin
    Tantry, Udaya S.
    Gurbel, Paul A.
    Lundgren, Scott W.
    AMERICAN JOURNAL OF THERAPEUTICS, 2024, 31 (06)
  • [34] Bexagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, for improvement of glycemia in type 2 diabetes mellitus: a systematic review and meta-analysis
    Dholariya, Sagar
    Dutta, Siddhartha
    Singh, Ragini
    Parchwani, Deepak
    Sonagra, Amit
    Kaliya, Mehul
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (18) : 2187 - 2198
  • [35] WEIGHT LOSS EFFECT OF SODIUM-GLUCOSE COTRANSPORTER-2 (SGLT2) INHIBITORS IN PATIENTS WITH OBESITY WITHOUT DIABETES: A SYSTEMATIC REVIEW
    Pratama, K. G.
    Tandarto, K.
    Hengky, A.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2022, 18 (02) : 216 - 224
  • [36] Sodium-glucose cotransporter 2 inhibitors and cancer: a systematic review and meta-analysis
    Xu, B.
    Kang, B.
    Li, S.
    Fan, S.
    Zhou, J.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2024, 47 (10) : 2421 - 2436
  • [37] Impact of Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) Use in Kidney Transplant Recipients
    Arnaldi, M.
    Alzaneen, G. K.
    House, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S606 - S607
  • [38] Sodium-glucose cotransporter 2 (SGLT-2) inhibitors and microvascular outcomes in patients with type 2 diabetes: systematic review and meta-analysis
    E. G. Dorsey-Treviño
    J. G. González-González
    N. Alvarez-Villalobos
    V. González-Nava
    B. M. Contreras-Garza
    A. Díaz González-Colmenero
    G. Rodríguez-Tamez
    F. J. Barrera-Flores
    A. M. Farrell
    V. M. Montori
    R. Rodriguez-Gutierrez
    Journal of Endocrinological Investigation, 2020, 43 : 289 - 304
  • [39] Sodium-glucose cotransporter 2 (SGLT-2) inhibitors and microvascular outcomes in patients with type 2 diabetes: systematic review and meta-analysis
    Dorsey-Trevino, E. G.
    Gonzalez-Gonzalez, J. G.
    Alvarez-Villalobos, N.
    Gonzalez-Nava, V
    Contreras-Garza, B. M.
    Diaz Gonzalez-Colmenero, A.
    Rodriguez-Tamez, G.
    Barrera-Flores, F. J.
    Farrell, A. M.
    Montori, V. M.
    Rodriguez-Gutierrez, R.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2020, 43 (03) : 289 - 304
  • [40] Sodium-glucose cotransporter-2 inhibitors and cancer outcomes: A systematic review and meta-analysis of randomized controlled trials
    Spiazzi, Bernardo F.
    Naibo, Rafaella A.
    Wayerbacher, Laura F.
    Piccoli, Giovana F.
    Farenzena, Laura P.
    Londero, Thiza M.
    da Natividade, Gabriella R.
    Zoldan, Maira
    Degobi, Nathalia A. H.
    Niches, Matheus
    Lopes, Gilberto
    Boyko, Edward J.
    Utzschneider, Kristina M.
    Colpani, Veronica
    Gerchman, Fernando
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 198